Research Topics
| Gary M OderdaSummaryAffiliation: University of Utah Country: USA Publications
| Collaborators
|
Detail Information
Publications
Effect of opioid-related adverse events on outcomes in selected surgical patientsGary M Oderda
Department of Pharmacotherapy, Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, UT 84112, USA
J Pain Palliat Care Pharmacother 27:62-70. 2013..This retrospective study utilized a large, national hospital database to assess the impact of opioid-related adverse events (ORADE) on patient outcomes following selected surgical procedures known to require postoperative pain control...- Challenges in the management of acute postsurgical painGary Oderda
Pharmacotherapy Outcomes Research Center, University of Utah College of Pharmacy, Salt Lake City, Utah 84112, USA
Pharmacotherapy 32:6S-11S. 2012..Strategies to reduce the use of opioids after surgery are likely to result in positive outcomes by reducing the incidence of ORADEs and, as a result, reducing treatment costs associated with surgery and improving patient care... 
The importance of perspective in pharmacoeconomic analysesGary M Oderda
College of Pharmacy, and Pain Research Center, University of Utah Health Sciences Center, Salt Lake City, USA
J Pain Palliat Care Pharmacother 16:65-9. 2002..The most common perspectives are those of providers, payers, patients, and society. The societal perspective is broadest and is usually preferred...- Cost-of-illness studiesGary M Oderda
College of Pharmacy, Pain Management Outcomes and Pharmacoeconomics Research Center, University of Utah Health Sciences Center, USA
J Pain Palliat Care Pharmacother 17:59-62. 2003..Comparison of cost-of-illness studies from different countries is difficult because of differences in population, currency, the way health care is provided, and other social and political factors... - Outcomes research: what it is and what it isn'tGary M Oderda
College of Pharmacy and Pain Research Center, University of Utah Health Sciences Center, USA
J Pain Palliat Care Pharmacother 16:83-9. 2002..To the contrary, outcomes research is a powerful tool, but like many others it has limitations and it is important to understand both what outcomes research is, and what it isn't... - Comparative effectiveness research (CER): a summary of AHRQ's CER on therapies for rheumatoid arthritisGary M Oderda
University of Utah Pharmacotherapy Outcomes Research Center, Salt Lake City, Utah 84108, USA
J Manag Care Pharm 17:S19-24. 2011..The overall goals of CER are to support informed health care decisions by patients, clinicians, payers, and policy makers and to apply its evidence to ultimately improve the quality, effectiveness, and efficiency of health care... - Agreement between pharmacists for problem identification: an initial quality measurement of cognitive servicesJoanne LaFleur
Drug Regimen Review Center, Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA
Ann Pharmacother 43:1173-80. 2009..A preliminary step in assessing quality is to compare agreement between pharmacists for basic problem identification... - Costs of opioid abuse and misuse determined from a Medicaid databaseCarrie McAdam-Marx
University of Utah, Salt Lake City, Utah, USA
J Pain Palliat Care Pharmacother 24:5-18. 2010..Successful interventions to prevent opioid abuse and manage comorbidities could help to reduce costs associated with opioid abuse in the Medicaid population... - Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stayGary M Oderda
Pharmacotherapy Outcomes Research Center, University of Utah Health Sciences Center, Salt Lake City, UT 84108, USA
Ann Pharmacother 41:400-6. 2007..Opioid analgesics remain a mainstay in the treatment of pain associated with surgical procedures. Such use is associated with adverse drug events (ADEs)... - Economic evaluation of pharmacotherapy of migraine pain: a review of the literatureJunhua Yu
Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah 84108, USA
J Pain Palliat Care Pharmacother 23:396-408. 2009..Alternative treatment and health outcome measures are defined and data sources described while methods for assessing the direct and indirect costs are explored. Directions for future research are identified and discussed... - Systematic analysis of outcomes evaluations applied to drug management programsCarrie McAdam-Marx
Department of Pharmacotherapy, University of Utah, 421 Wakara Wy, Rm 208, Salt Lake City, UT 84108, USA
Am J Manag Care 14:SP36-45. 2008..To evaluate prior analyses that quantify how drug management programs impact health plans and patients with respect to those analyses' effectiveness in measuring program quality... - Prevalence of drug-related problems and cost-savings opportunities in medicaid high utilizers identified by a pharmacist-run drug regimen review centerJoanne LaFleur
Drug Regimen Review Center, Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USA
J Manag Care Pharm 12:677-85. 2006..The DUR program was designed to suggest ways that high-utilizing patients could decrease their total number of medications to 7 or fewer prior to imposition of the 7-medication limit at some time in the future... - Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolismFreddy M Creekmore
College of Pharmacy, University of Utah, Salt Lake City, Utah 84112
Pharmacotherapy 26:1438-45. 2006.... - Economic evaluations in pain management: principles and methodsCarl V Asche
Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, University of Utah College of Pharmacy, 421 Wakara Way, Suite 208, Salt Lake City, UT 84108, USA
J Pain Palliat Care Pharmacother 20:15-23. 2006.... - Adherence and persistence with single-dosage form extended-release niacin/lovastatin compared with statins alone or in combination with extended-release niacinJoanne LaFleur
Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, 84108, USA
Ann Pharmacother 40:1274-9. 2006..A fixed-dose combination product, extended-release niacin/lovastatin (ERNL), has been shown to be beneficial in lipid management; however, little is known regarding patient behavior with ERNL therapy... - Opioid expenditures and utilization in the Medicaid systemDiana I Brixner
Department of Pharmacotheraphy, University of Utah, Salt Lake City, UT 84112, USA
J Pain Palliat Care Pharmacother 20:5-13. 2006..By 2003, opioids represented about a four percent share of all Medicaid prescription drugs. Variations among the states in per-enrollee spending on opioids are substantial. The appropriateness of these variations is unknown... - Naturalistic impact of second-generation antipsychotics on weight gainDiana I Brixner
Executive Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, UT 84108, USA
Ann Pharmacother 40:626-32. 2006..Body mass index (BMI) has been studied in clinical trials with limited comparison between drugs... - Documentation of chemotherapy infusion preparation costs in academic- and community-based oncology practicesDiana I Brixner
University of Utah Pharmacotherapy Outcomes Research Center, Salt Lake City, Utah, 84108, USA
J Natl Compr Canc Netw 4:197-208. 2006..These data provide scientific support for the consideration of appropriate reimbursement for chemotherapy services provided by pharmacists to Medicare beneficiaries... - Cost of opioid-related adverse drug events in surgical patientsGary M Oderda
University of Utah College of Pharmacy and School of Medicine, Salt Lake City, UT, USA
J Pain Symptom Manage 25:276-83. 2003..The estimated log cost difference of 16%, if applied to the median cost patient in the non-ADE group, averaged US$ 840. Opioid-related ADEs are common in hospitalized patients and increase LOS and total hospital costs... - Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugsJoseph E Biskupiak
Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, University of Utah College of Pharmacy, 421 Wakara Way, Suite 208, Salt Lake City, UT 84108, USA
J Pain Palliat Care Pharmacother 20:7-14. 2006.... - The association between pain and depression and some determinants of depression for the general population of the United StatesBeilei Cai
Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah 84108, USA
J Pain Palliat Care Pharmacother 26:257-65. 2012..Levels of physical pain and many socioeconomic factors were found significantly associated with depression... - The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims databaseVijay N Joish
Pharmacotherapy Outcomes Research Center, University of Utah College of Pharmacy, Salt Lake City, UT, USA
Curr Med Res Opin 21:535-44. 2005..CONCLUSIONS: Direct medical cost and work absence in employees with GERD, PUD and GERD + PUD represent a significant burden to employees and employers... - Cost-utility analysis and quality adjusted life yearsVijay N Joish
College of Pharmacy, Pharmacotherapy Outcomes Research Center, University of Utah Health Sciences Center, Salt Lake City, UT 84108, USA
J Pain Palliat Care Pharmacother 19:57-61. 2005..This article provides an overview of cost utility analysis and quality adjusted life years, a commonly used effectiveness measure in CUA when comparing two or more treatments or interventions... - Methods to measure patient compliance with medication regimensJoanne LaFleur
Pharmacotherpay Outcomes Research Center, University of Utah, Salt Lake City, UT 84108, USA
J Pain Palliat Care Pharmacother 18:81-7. 2004..Objective methods include pill counting, electronic monitoring devices, and data reviews; these methods vary in cost and reliability... - Providing diabetes education and care to underserved patients in a collaborative practice at a utah community health centerLaura Shane-McWhorter
Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah 84112, USA
Pharmacotherapy 25:96-109. 2005..However, more patients who were provided care by the pharmacist CDE reached the American Diabetes Association A1C target goal of below 7%... - National survey of pharmacist certified diabetes educatorsLaura Shane-McWhorter
Department of Pharmacy Practice, University of Utah, College of Pharmacy, 30 South 2000 E #260, Salt Lake City, UT 84112, USA
Pharmacotherapy 22:1579-93. 2002..Pharmacists are often the most accessible of all health care providers, and earning the CDE credential may be an important contribution to diabetes care and education... - Older and younger adults in pain management programs in the United States: differences and similaritiesHarriet M Wittink
Department of Physical Therapy, University of Professional Education and Academy of Health Sciences Utrecht, Utrecht University, Utrecht, The Netherlands
Pain Med 7:151-63. 2006.... - Has the cost-effectiveness of Xolair (omalizumab) been underestimated?Carl V Asche
J Allergy Clin Immunol 115:1095; author reply 1095-6. 2005